vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and GLOBAL INDUSTRIAL Co (GIC). Click either name above to swap in a different company.
GLOBAL INDUSTRIAL Co is the larger business by last-quarter revenue ($345.6M vs $263.6M, roughly 1.3× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 4.2%, a 10.7% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs 9.8%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs 3.4%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
BCPC vs GIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $345.6M |
| Net Profit | $39.2M | $14.6M |
| Gross Margin | 35.6% | 34.5% |
| Operating Margin | 19.8% | 5.7% |
| Net Margin | 14.9% | 4.2% |
| Revenue YoY | 9.8% | 14.3% |
| Net Profit YoY | 16.8% | 36.4% |
| EPS (diluted) | $1.21 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $345.6M | ||
| Q3 25 | $267.6M | $353.6M | ||
| Q2 25 | $255.5M | $358.9M | ||
| Q1 25 | $250.5M | $321.0M | ||
| Q4 24 | $240.0M | $302.3M | ||
| Q3 24 | $239.9M | $342.4M | ||
| Q2 24 | $234.1M | $347.8M | ||
| Q1 24 | $239.7M | $323.4M |
| Q4 25 | $39.2M | $14.6M | ||
| Q3 25 | $40.3M | $18.8M | ||
| Q2 25 | $38.3M | $25.1M | ||
| Q1 25 | $37.1M | $13.6M | ||
| Q4 24 | $33.6M | $10.7M | ||
| Q3 24 | $33.8M | $16.8M | ||
| Q2 24 | $32.1M | $20.3M | ||
| Q1 24 | $29.0M | $13.2M |
| Q4 25 | 35.6% | 34.5% | ||
| Q3 25 | 35.7% | 35.6% | ||
| Q2 25 | 36.4% | 37.1% | ||
| Q1 25 | 35.2% | 34.9% | ||
| Q4 24 | 36.0% | 33.8% | ||
| Q3 24 | 35.6% | 34.0% | ||
| Q2 24 | 35.5% | 35.2% | ||
| Q1 24 | 34.0% | 34.3% |
| Q4 25 | 19.8% | 5.7% | ||
| Q3 25 | 20.4% | 7.4% | ||
| Q2 25 | 20.1% | 9.3% | ||
| Q1 25 | 20.4% | 5.7% | ||
| Q4 24 | 19.8% | 4.8% | ||
| Q3 24 | 20.0% | 6.5% | ||
| Q2 24 | 19.6% | 7.6% | ||
| Q1 24 | 17.4% | 5.4% |
| Q4 25 | 14.9% | 4.2% | ||
| Q3 25 | 15.1% | 5.3% | ||
| Q2 25 | 15.0% | 7.0% | ||
| Q1 25 | 14.8% | 4.2% | ||
| Q4 24 | 14.0% | 3.5% | ||
| Q3 24 | 14.1% | 4.9% | ||
| Q2 24 | 13.7% | 5.8% | ||
| Q1 24 | 12.1% | 4.1% |
| Q4 25 | $1.21 | $0.37 | ||
| Q3 25 | $1.24 | $0.48 | ||
| Q2 25 | $1.17 | $0.65 | ||
| Q1 25 | $1.13 | $0.35 | ||
| Q4 24 | $1.03 | $0.28 | ||
| Q3 24 | $1.03 | $0.44 | ||
| Q2 24 | $0.98 | $0.52 | ||
| Q1 24 | $0.89 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $67.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $313.2M |
| Total Assets | $1.7B | $580.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $67.5M | ||
| Q3 25 | $65.1M | $67.2M | ||
| Q2 25 | $65.4M | $55.1M | ||
| Q1 25 | $49.9M | $39.0M | ||
| Q4 24 | $49.5M | $44.6M | ||
| Q3 24 | $73.7M | $38.9M | ||
| Q2 24 | $63.7M | $38.8M | ||
| Q1 24 | $60.3M | $29.9M |
| Q4 25 | $1.3B | $313.2M | ||
| Q3 25 | $1.3B | $316.0M | ||
| Q2 25 | $1.3B | $305.2M | ||
| Q1 25 | $1.2B | $287.9M | ||
| Q4 24 | $1.1B | $281.1M | ||
| Q3 24 | $1.2B | $279.2M | ||
| Q2 24 | $1.1B | $270.4M | ||
| Q1 24 | $1.1B | $260.2M |
| Q4 25 | $1.7B | $580.8M | ||
| Q3 25 | $1.7B | $602.5M | ||
| Q2 25 | $1.7B | $586.5M | ||
| Q1 25 | $1.6B | $536.7M | ||
| Q4 24 | $1.6B | $520.7M | ||
| Q3 24 | $1.6B | $531.6M | ||
| Q2 24 | $1.6B | $542.5M | ||
| Q1 24 | $1.6B | $517.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $20.0M |
| Free Cash FlowOCF − Capex | — | $19.2M |
| FCF MarginFCF / Revenue | — | 5.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 1.72× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | $74.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $20.0M | ||
| Q3 25 | $65.6M | $22.7M | ||
| Q2 25 | $47.3M | $31.7M | ||
| Q1 25 | $36.5M | $3.4M | ||
| Q4 24 | $52.3M | $15.9M | ||
| Q3 24 | $51.3M | $9.6M | ||
| Q2 24 | $45.0M | $18.8M | ||
| Q1 24 | $33.4M | $6.4M |
| Q4 25 | — | $19.2M | ||
| Q3 25 | — | $22.0M | ||
| Q2 25 | — | $30.3M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $8.7M | ||
| Q2 24 | — | $17.9M | ||
| Q1 24 | — | $5.1M |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | 1.72× | 1.37× | ||
| Q3 25 | 1.63× | 1.21× | ||
| Q2 25 | 1.23× | 1.26× | ||
| Q1 25 | 0.98× | 0.25× | ||
| Q4 24 | 1.56× | 1.49× | ||
| Q3 24 | 1.52× | 0.57× | ||
| Q2 24 | 1.40× | 0.93× | ||
| Q1 24 | 1.15× | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
GIC
Segment breakdown not available.
